• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

几丁质酶-3样蛋白1通过损害巨噬细胞的胞葬作用降低动脉粥样硬化斑块的稳定性。

Chitinase-3-like Protein 1 Reduces the Stability of Atherosclerotic Plaque via Impairing Macrophagic Efferocytosis.

作者信息

Liu Yandong, Hu Weilin, Yang Futang, Zou Sili, Ren Huiqiong, Zuo Yong, Qu Lefeng

机构信息

Department of Geriatrics, 905, Hospital of PLA NAVY, Shanghai, China.

Department of Vascular and Endovascular Surgery, Changzheng Hospital, Affiliated to the Naval Medical University, Shanghai, 200003, China.

出版信息

J Cardiovasc Transl Res. 2025 Feb;18(1):3-16. doi: 10.1007/s12265-024-10576-w. Epub 2025 Jan 15.

DOI:10.1007/s12265-024-10576-w
PMID:39813006
Abstract

CHI3L1 is strongly associated with atherosclerosis, but its role in macrophages remains unknown. In this study, we observed a significant up-regulation of CHI3L1 in both carotid plaques and serum of symptomatic patients, and demonstrated that CHI3L1 impairs the efferocytosis of macrophages by down-regulating crucial efferocytic mediator MFGE8 through inhibiting ATF2, which binds directly to the enhancer of MFGE8. In human plaques, we observed a negative correlation between CHI3L1 expression and both ATF2 and MFGE8 levels, further proved their involvement in plaque destabilization. Using Ldlr-/- mice with tandem carotid stenosis surgery, we demonstrated that administration of CHI3L1 protein resulted in enlarged atherosclerotic necrotic cores and decreased MFGE8 and ATF2 levels. Conversely, treatment with a CHI3L1 blocking antibody exhibited the opposite trend.In conclusion, CHI3L1 destabilizes atherosclerotic plaque by impairing macrophagic efferocytosis through the down-regulation of ATF2-induced MFGE8 expression. Targeting CHI3L1 may offer a promising therapeutic strategy for the treatment of atherosclerosis.

摘要

几丁质酶3样蛋白1(CHI3L1)与动脉粥样硬化密切相关,但其在巨噬细胞中的作用尚不清楚。在本研究中,我们观察到有症状患者的颈动脉斑块和血清中CHI3L1均显著上调,并证明CHI3L1通过抑制直接结合到牛奶脂肪球表皮生长因子8(MFGE8)增强子的活化转录因子2(ATF2),下调关键的胞葬作用介质MFGE8,从而损害巨噬细胞的胞葬作用。在人类斑块中,我们观察到CHI3L1表达与ATF2和MFGE8水平均呈负相关,进一步证明它们参与了斑块的不稳定。使用串联颈动脉狭窄手术的载脂蛋白E基因敲除(Ldlr-/-)小鼠,我们证明给予CHI3L1蛋白会导致动脉粥样硬化坏死核心增大,MFGE8和ATF2水平降低。相反,用CHI3L1阻断抗体治疗则呈现相反的趋势。总之,CHI3L1通过下调ATF2诱导的MFGE8表达损害巨噬细胞胞葬作用,从而使动脉粥样硬化斑块不稳定。靶向CHI3L1可能为动脉粥样硬化的治疗提供一种有前景的治疗策略。

相似文献

1
Chitinase-3-like Protein 1 Reduces the Stability of Atherosclerotic Plaque via Impairing Macrophagic Efferocytosis.几丁质酶-3样蛋白1通过损害巨噬细胞的胞葬作用降低动脉粥样硬化斑块的稳定性。
J Cardiovasc Transl Res. 2025 Feb;18(1):3-16. doi: 10.1007/s12265-024-10576-w. Epub 2025 Jan 15.
2
Chitinase 3 like 1 is a regulator of smooth muscle cell physiology and atherosclerotic lesion stability.几丁质酶3样蛋白1是平滑肌细胞生理功能和动脉粥样硬化病变稳定性的调节因子。
Cardiovasc Res. 2021 Dec 17;117(14):2767-2780. doi: 10.1093/cvr/cvab014.
3
Reduction of TMAO level enhances the stability of carotid atherosclerotic plaque through promoting macrophage M2 polarization and efferocytosis.通过促进巨噬细胞 M2 极化和吞噬作用,降低 TMAO 水平可增强颈动脉粥样硬化斑块的稳定性。
Biosci Rep. 2021 May 28;41(6). doi: 10.1042/BSR20204250.
4
Limited Macrophage Positional Dynamics in Progressing or Regressing Murine Atherosclerotic Plaques-Brief Report.进展或消退的小鼠动脉粥样硬化斑块中有限的巨噬细胞位置动态变化-简短报告。
Arterioscler Thromb Vasc Biol. 2018 Aug;38(8):1702-1710. doi: 10.1161/ATVBAHA.118.311319.
5
Correlation between SHP-1 and carotid plaque vulnerability in humans.SHP-1 与人颈动脉斑块易损性的相关性。
Cardiovasc Pathol. 2020 Nov-Dec;49:107258. doi: 10.1016/j.carpath.2020.107258. Epub 2020 Jun 24.
6
MerTK receptor cleavage promotes plaque necrosis and defective resolution in atherosclerosis.MerTK受体裂解促进动脉粥样硬化中的斑块坏死和溶解缺陷。
J Clin Invest. 2017 Feb 1;127(2):564-568. doi: 10.1172/JCI90520. Epub 2017 Jan 9.
7
CAMKIIγ suppresses an efferocytosis pathway in macrophages and promotes atherosclerotic plaque necrosis.钙/钙调蛋白依赖性蛋白激酶IIγ(CAMKIIγ)抑制巨噬细胞的胞葬作用途径并促进动脉粥样硬化斑块坏死。
J Clin Invest. 2017 Nov 1;127(11):4075-4089. doi: 10.1172/JCI94735. Epub 2017 Oct 3.
8
Akt2/LDLr double knockout mice display impaired glucose tolerance and develop more complex atherosclerotic plaques than LDLr knockout mice.Akt2/LDLr 双敲除小鼠表现出葡萄糖耐量受损,并比 LDLr 敲除小鼠发展出更复杂的动脉粥样硬化斑块。
Cardiovasc Res. 2014 Feb 1;101(2):277-87. doi: 10.1093/cvr/cvt252. Epub 2013 Nov 12.
9
NLRP3 Inflammasome Inhibition by MCC950 Reduces Atherosclerotic Lesion Development in Apolipoprotein E-Deficient Mice-Brief Report.MCC950对NLRP3炎性小体的抑制作用可减少载脂蛋白E缺乏小鼠的动脉粥样硬化病变发展——简要报告
Arterioscler Thromb Vasc Biol. 2017 Aug;37(8):1457-1461. doi: 10.1161/ATVBAHA.117.309575. Epub 2017 Jun 8.
10
Reversal of hypoxia in murine atherosclerosis prevents necrotic core expansion by enhancing efferocytosis.在鼠动脉粥样硬化中逆转缺氧可通过增强噬作用来防止坏死核心扩张。
Arterioscler Thromb Vasc Biol. 2014 Dec;34(12):2545-53. doi: 10.1161/ATVBAHA.114.304023. Epub 2014 Sep 25.

引用本文的文献

1
Correlation between dyslipidaemia and gastric cancer: pathogenesis to prevention and treatment strategies.血脂异常与胃癌之间的关联:从发病机制到预防及治疗策略
Lipids Health Dis. 2025 Jun 7;24(1):204. doi: 10.1186/s12944-025-02625-3.
2
Best Paper of the Year 2024.2024年度最佳论文。
J Cardiovasc Transl Res. 2025 Feb;18(1):1-2. doi: 10.1007/s12265-025-10595-1.

本文引用的文献

1
Serum YKL-40 in coronary heart disease: linkage with inflammatory cytokines, artery stenosis, and optimal cut-off value for estimating major adverse cardiovascular events.冠心病患者血清YKL-40水平:与炎症细胞因子、动脉狭窄的关联及评估主要不良心血管事件的最佳临界值
Front Cardiovasc Med. 2023 Oct 31;10:1242339. doi: 10.3389/fcvm.2023.1242339. eCollection 2023.
2
Macrophage polarization and metabolism in atherosclerosis.动脉粥样硬化中的巨噬细胞极化和代谢。
Cell Death Dis. 2023 Oct 20;14(10):691. doi: 10.1038/s41419-023-06206-z.
3
Phenotypic Switching of Vascular Smooth Muscle Cells in Atherosclerosis.
动脉粥样硬化中血管平滑肌细胞的表型转换。
J Am Heart Assoc. 2023 Oct 17;12(20):e031121. doi: 10.1161/JAHA.123.031121. Epub 2023 Oct 10.
4
Medical and Surgical Management of Symptomatic and Asymptomatic Carotid Artery Stenosis: A Comprehensive Literature Review.有症状和无症状颈动脉狭窄的医学与外科治疗:一项全面的文献综述
Cureus. 2023 Aug 10;15(8):e43263. doi: 10.7759/cureus.43263. eCollection 2023 Aug.
5
Serum CHI3L1 as a biomarker of interstitial lung disease in rheumatoid arthritis.血清 CHI3L1 作为类风湿关节炎间质性肺病的生物标志物。
Front Immunol. 2023 Aug 17;14:1211790. doi: 10.3389/fimmu.2023.1211790. eCollection 2023.
6
Interplay between efferocytosis and atherosclerosis.噬菌作用与动脉粥样硬化之间的相互作用。
Arch Cardiovasc Dis. 2023 Oct;116(10):474-484. doi: 10.1016/j.acvd.2023.07.007. Epub 2023 Aug 18.
7
ChIP and ChIRP Assays in Ferroptosis.ChIP 和 ChIRP assays 在铁死亡中的应用。
Methods Mol Biol. 2023;2712:19-27. doi: 10.1007/978-1-0716-3433-2_3.
8
Association of serum YKL-40 change with prognosis in acute ischemic stroke patients complicated with diabetes mellitus.血清 YKL-40 变化与合并糖尿病的急性缺血性脑卒中患者预后的关系。
Biomark Med. 2023 Mar;17(5):253-263. doi: 10.2217/bmm-2023-0108. Epub 2023 May 31.
9
Do Elevated YKL-40 Levels Drive the Immunosuppressive Tumor Microenvironment in Colorectal Cancer? Assessment of the Association of the Expression of YKL-40, MMP-8, IL17A, and PD-L1 with Coexisting Type 2 Diabetes, Obesity, and Active Smoking.YKL-40水平升高是否驱动结直肠癌中的免疫抑制肿瘤微环境?评估YKL-40、MMP-8、IL17A和PD-L1的表达与并存的2型糖尿病、肥胖和主动吸烟之间的关联。
Curr Issues Mol Biol. 2023 Mar 27;45(4):2781-2797. doi: 10.3390/cimb45040182.
10
The Role of Macrophages in the Pathogenesis of Atherosclerosis.巨噬细胞在动脉粥样硬化发病机制中的作用。
Cells. 2023 Feb 5;12(4):522. doi: 10.3390/cells12040522.